(Q85226494)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Prognostic factors for survival in melanoma patients with brain metastases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

7

Patrick Hwu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Ping Liu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Susan McIntyre

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Nicholas Papadopoulos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Wen-Jen Hwu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Agop Bedikian

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Michael A. Davies

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20960525

6 August 2024

Kevin B. Kim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20960525

6 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20960525

6 August 2024

publication date

19 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960525%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

15 February 2020

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.25634

1 reference

https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.25634

6 August 2024

1 reference

6 August 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

1687-1696

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

Determinants of outcome in melanoma patients with cerebral metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

Cranial irradiation after surgical excision of brain metastases in melanoma patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

Pilot study of preoperative chemotherapy with cisplatin, vinblastine, and dacarbazine in patients with local-regional recurrence of melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-alpha

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

Multidisciplinary management of brain metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

Treatment of brain metastases of malignant melanoma with temozolomide

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

Temozolomide: a novel oral alkylating agent

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

Complete response of multiple melanoma brain metastases after treatment with temozolomide

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

Leptomeningeal metastases from solid malignancy: a review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

Primary leptomeningeal melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

Unusual cases involving the CNS and nasal sinuses: Case 1. Primary leptomeningeal melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain: high rate of thromboembolic events (CALGB 500102).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25634

7 January 2021

Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy

8

1 reference

Analysis of the genome to personalize therapy for melanoma

6 August 2024

34

1 reference

6 August 2024

Identifiers

DOI

10.1002/CNCR.25634

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference